Italy Blood-based Biomaker For Sports Medicine Market Size & Outlook
Italy blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Italy blood-based biomaker for sports medicine market highlights
- The Italy blood-based biomaker for sports medicine market generated a revenue of USD 17.9 million in 2023 and is expected to reach USD 31.4 million by 2030.
- The Italy market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 17.9 million |
| Market revenue in 2030 | USD 31.4 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 17.88% in 2023. Horizon Databook has segmented the Italy blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Sports participation in Italy has increased, contributing significantly to the country’s economy. According to a report by the Rome Business School in October 2023, the sports sector in Italy now accounts for over 3.4% of the nation’s GDP. This growth is driven by the increasing popularity of various sports, including soccer, swimming, cycling, and esports.
Over the past 3 years, the revenues of the sports sector have seen a steady increase of 6%, reflecting the expanding interest and investment in sports. As the sports sector in Italy continues to flourish, the market for sports medicine, particularly blood based biomarkers, is expected to witness significant growth over the forecast period.
Blood-based biomarkers are becoming increasingly important in sports medicine for monitoring athlete health, predicting injury risk, and optimizing performance. The integration of these biomarkers into sports medicine practices in Italy is aiding in the development of more personalized & effective treatment and prevention strategies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Italy Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
